Focusing on frequent ASXL1 mutations in myeloid neoplasms, and considering rarer ASXL2 and ASXL3 mutations

被引：8
|
作者：
Oak, Jean S. [1 ]
Ohgami, Robert S. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2017年 / 33卷 / 04期
关键词：
LEUKEMIA; GENES;
D O I：
10.1080/03007995.2017.1284049
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：781 / 782
页数：2
相关论文
共 50 条
  • [41] ANALYSIS OF ASXL1 MUTATIONS AND CORRELATION WITH CHROMOSOMAL ALTERATIONS IN ACUTE MYELOID LEUKEMIA
    Kakosaiou, K.
    Daraki, A.
    Apostolou, P.
    Zachaki, S.
    Pagoni, M.
    Sambani, C.
    Dimitriadis, G.
    Pappa, V.
    Manola, K.
    HAEMATOLOGICA, 2015, 100 : 359 - 360
  • [42] Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
    Lasho, Terra L.
    Vallapureddy, Rangit
    Finke, Christy M.
    Mangaonkar, Abhishek
    Gangat, Naseema
    Ketterling, Rhett
    Tefferi, Ayalew
    Patnaik, Mrinal M.
    BLOOD CANCER JOURNAL, 2018, 8
  • [43] PROGNOSTIC VALUE OF MUTATIONS IN ASXL1 IN CHRONIC MYELOMONOCYTIC LEUKEMIA
    Almorox Rebeca, Bailen
    Gonzalez Julia, Suarez
    Carolina, Martinez-Laperche
    Noemi, Fernandez-Escalada
    Maria, Chicano-Lavilla
    Diego, Carbonell
    Patricia, Font
    Santiago, Osorio
    Jose Lui, Diez-Martin
    Ismael, Buno
    HAEMATOLOGICA, 2016, 101 : 153 - 154
  • [44] Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex
    Balasubramani, Anand
    Larjo, Antti
    Bassein, Jed A.
    Chang, Xing
    Hastie, Ryan B.
    Togher, Susan M.
    Lahdesmaki, Harri
    Rao, Anjana
    NATURE COMMUNICATIONS, 2015, 6
  • [45] Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation
    West, Robert R.
    Hsu, Amy P.
    Holland, Steven M.
    Cuellar-Rodriguez, Jennifer
    Hickstein, Dennis D.
    HAEMATOLOGICA, 2014, 99 (02) : 276 - 281
  • [46] ASXL1 Mutations in AML: Molecular Biomarker for Secondary AML?
    Hsu, Jingmei
    Kumar, Anita
    Carroll, Martin
    Frey, Noelle
    Shah, Nirav
    Zhao, Jianhua
    Hexner, Elizabeth
    Loren, Alison
    Perl, Alexander
    Porter, David
    Morrissette, Jennifer
    Luger, Selina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S195 - S195
  • [47] Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
    Véronique Gelsi-Boyer
    Mandy Brecqueville
    Raynier Devillier
    Anne Murati
    Marie-Joelle Mozziconacci
    Daniel Birnbaum
    Journal of Hematology & Oncology, 5
  • [48] Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms
    Asada, Shuhei
    Kitamura, Toshio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (02) : 179 - 186
  • [49] Coordinate regulation of chromatin state by JAK2 and ASXL1 mutations in myeloid malignancies
    LaFave, Lindsay M.
    Chung, Young Rock
    Keller, Matt
    Kleppe, Maria
    Mullally, Ann
    Abdel-Wahab, Omar
    Levine, Ross L.
    CANCER RESEARCH, 2013, 73
  • [50] Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
    Gelsi-Boyer, Veronique
    Brecqueville, Mandy
    Devillier, Raynier
    Murati, Anne
    Mozziconacci, Marie-Joelle
    Birnbaum, Daniel
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
12345